Psoriasis Current Events

Psoriasis Current Events, Psoriasis News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 14 | 534 Results
Study examines sex differences in potential link between psoriasis and metabolic disorders
An analysis published in the Journal of the European Academy of Dermatology and Venereology revealed considerable sex differences when considering links between psoriasis and metabolic disorders. (2019-12-04)

Psoriasis and psychiatric illnesses: What are the links?
A new review examines the potential link between psoriasis and mental health conditions. (2017-08-11)

Psoriasis linked with need for cardiovascular interventions in patients with hypertension
Psoriasis is linked with increased risks of hypertension and cardiovascular disease, but its effect on the course of cardiovascular disease remains unknown. (2018-10-17)

Psoriasis and smoking: Links and risks published by Dove Medical Press
Smoking impacts on the clinical severity of psoriasis, its response to treatment and explains some of the associated co-morbidities, e.g., cardiovascular disease, inflammatory bowel disease, and several cancers (especially those of the respiratory tract). (2016-05-30)

Uncontrolled hypertension highest among patients with moderate-to-severe psoriasis
Patients with moderate and severe psoriasis have the greatest likelihood of uncontrolled hypertension compared to patients without psoriasis. (2014-10-15)

Scratching an itch: Neutralizing IL-22 prevents psoriasis in mice
Psoriasis, which is a chronic disease characterized by the development of red, scaly, raised skin lesions, affects approximately 2 percent of the population of countries of the Western world. A new study has now provided evidence that the soluble molecule IL-22 is central to the development of disease in a mouse model of psoriasis, leading to the suggestion that antagonizing IL-22 might provide a new approach to treating individuals with psoriasis. (2008-01-17)

Psoriasis patients' mental health is more than skin-deep
A new study from Umeå University, Sweden, shows that other somatic diseases have even more impact on patients' mental health than their skin symptoms, highlighting the importance of holistic patient care. (2020-06-04)

National Psoriasis Foundation awards more than $2 million for research
Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis -- the most common autoimmune disease in the country, affecting as many as 7.5 million Americans -- and psoriatic arthritis, an inflammatory joint and tendon disease. (2012-05-15)

U-M researchers receive largest single collection of psoriasis DNA samples
Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the release of the first National Psoriasis Victor Henschel BioBank DNA samples for use in research at the University of Michigan Health System; research that hopes to uncover the unknowns about the genetics of psoriasis and psoriatic arthritis. (2010-09-01)

National Psoriasis Foundation awards inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship
The National Psoriasis Foundation awarded Zelma Chiesa Fuxench, M.D., of the University of Pennsylvania, its inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship, recognizing her work as a promising psoriasis and psoriatic arthritis researcher. Dr. Chiesa received a one-year, $40,000 fellowship to study psoriasis, the most common autoimmune disease in the country. (2013-07-08)

Combining biologic and phototherapy treatments for moderate-to-severe psoriasis
Although the efficacy and safety of biologic and phototherapeutic treatments in treating moderate-to-severe psoriasis are well known, not all patients respond well to monotherapy and may require a combination of both types of therapy. There have been few studies investigating the safety and efficacy of combination treatment; now, a review published in the journal Psoriasis Targets and Therapy shows that combination treatment is safe and viable. (2016-08-09)

Severe psoriasis associated with increased risk of death
Patients with severe psoriasis appear to have an increased risk of death compared with patients without the skin condition, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. (2007-12-17)

Closer to the source of the itch
Scientists at Hokkaido University are getting closer to understanding the underlying mechanisms that lead to psoriasis. (2016-05-25)

Psoriasis, risk of depression in the US population
The chronic inflammatory skin condition psoriasis was associated with the risk of major depression, although the risk was unrelated to the severity of the disorder, according to an article published online by JAMA Dermatology. (2015-09-30)

Details revealed behind psoriasis and wound repair: 2 sides of the same coin
The dynamic properties of the skin that take charge when a cut or scrape needs healing are critical for maintaining the skin's integrity, but if they get out of control, they can cause problems in the form of psoriasis and other skin disorders. Researchers have now uncovered key information on how cells are stimulated to multiply during these processes. The information might be used to develop new treatments for psoriasis and hard-to-heal skin wounds. (2012-06-21)

New study shows smoking increases risk of psoriasis
Another disease can be added to the list of smoking-related disorders -- psoriasis. Researchers have found that smoking increases the risk of developing psoriasis, heavier smoking increases the risk further, and the risk decreases only slowly after quitting. Investigators from the Massachusetts General Hospital, Brigham and Women's Hospital, the Harvard School of Public Health, all in Boston, Mass., US, and Vancouver General Hospital, Vancouver, BC, Canada, have published the results in the November 2007 issue of The American Journal of Medicine. (2007-10-29)

Moderate to severe psoriasis linked to chronic kidney disease, say experts
Moderate to severe psoriasis is associated with an increased risk of chronic kidney disease independent of traditional risk factors, such as diabetes and heart disease, finds a study published on bmj.com today. (2013-10-15)

New psoriasis drug is more effective than current treatment
A phase II clinical trial led by Northwestern Medicine investigators shows that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care for the chronic skin condition. (2015-07-08)

Skin condition associated with depression, anxiety and suicidal feelings
Individuals with psoriasis appear to have an increased risk of depression, anxiety and suicidality, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. (2010-08-16)

Research opens new treatment strategies for specific form of psoriasis
Psoriasis is a long-lasting autoimmune disease that is characterized by patches of abnormal and inflamed skin. It is generally thought to have a genetic origin, which can be further triggered by environmental factors. People with specific mutations in the CARD14 gene have a high probability of developing psoriasis. A VIB/UGent research team now reveals the molecular signaling mechanism by which mutations in CARD14 lead to increased inflammation in patients with psoriasis. (2016-04-25)

Psoriasis associated with increased risk for heart attack
Adults with psoriasis, especially younger patients with severe psoriasis, appear to be at increased risk for a heart attack, according to a study in the October 11 issue of JAMA. (2006-10-10)

Patients with severe psoriasis suffer daily, study finds
Psoriasis significantly reduces quality of life, according to researchers at Wake Forest University Baptist Medical Center. (1999-09-02)

New drug can clear all psoriasis symptoms
A University of Manchester led trial of a new psoriasis drug has resulted in 40 percent of people showing a complete clearance of psoriatic plaques after 12 weeks of treatment and over 90 percent showing improvement. (2015-06-10)

Children with psoriasis may be at increased risk for overweight and obesity
A study of children in nine countries found that psoriasis in children was associated with an increased risk for overweight and obesity, regardless of psoriasis severity. (2012-11-19)

Researchers find gene that confirms existence of psoriatic arthritis
Researchers led by the Arthritis Research UK Centre for Genetics and Genomics at The University of Manchester have identified genetic variants that are associated with psoriatic arthritis but not with psoriasis, in the largest study of PsA ever published. (2015-02-05)

Psoriasis: Towards a novel therapeutic approach
Researchers at the Université libre de Bruxelles (ULB) and the Department of Dermatology of the Erasme hospital uncover the importance of VEGFA signaling in the epidermis to mediate psoriasis development. (2020-01-09)

Government psoriasis research funding down over last decade while NIH budget up 148%
Over the last decade, as NIH funding increased by 148%, psoriasis research funding at NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) actually decreased by 13%. (2004-05-17)

Popular alternative therapy for psoriasis performs no better than placebo
Anecdotal evidence touting the healing power of the Indian spice turmeric for psoriasis received a setback in a prospective study published this month by a leading dermatology journal stating that the low response rate of patients who ingested the active ingredient of the exotic spice was probably a result of the placebo effect. (2008-02-29)

Stimulating a protein in skin cells could improve psoriasis symptoms
Environmental contaminants can trigger psoriasis and other autoimmune disorders, and it is thought that a protein called the aryl hydrocarbon receptor, which senses environmental toxins, could play a role. A new study in Immunity shows that the severity of inflammation associated with psoriasis is unexpectedly suppressed by AhR. The findings suggest that stimulation of AhR could improve symptoms and may represent a novel strategy for treating chronic inflammatory skin disorders. (2014-06-05)

Drug for psoriasis may also relieve depression and fatigue linked to the disease
A drug used to treat the clinical symptoms of psoriasis may also relieve fatigue and depression associated with the disease, concludes a randomised trial published online today (Thursday December 15, 2005) by The Lancet. (2005-12-14)

Women who drink beer more likely to develop psoriasis
Regular beer -- but not light beer or other types of alcohol -- appears to be associated with an increased risk of developing psoriasis, according to a report posted online today that will be published in the December print issue of Archives of Dermatology, one of the JAMA/Archives journals. (2010-08-16)

Psoriasis may increase risk for certain cancers
Patients with the skin disease psoriasis may be at an increased risk for developing lymphoma, according to an article in the November issue of The Archives of Dermatology, one of the JAMA/Archives journals. (2003-11-17)

Study suggests that psoriasis may be associated with development of type 2 diabetes
A population-based study from the United Kingdom suggests that the common skin condition psoriasis may be a risk factor for the development of type 2 diabetes mellitus, according to a report published Online First by Archives of Dermatology, a JAMA Network publication. (2012-06-18)

Trial demonstrates new drug's effectiveness against psoriasis
A rheumatoid arthritis drug can successfully treat moderate to severe cases of the skin disease psoriasis, according to the results of a randomised trial published in this week's issue of The Lancet. (2005-10-13)

Review article estimates annual US cost of psoriasis in 2013
The annual US cost of psoriasis, a chronic inflammatory skin condition, was estimated to be between $112 billion and $135 billion in 2013, according to a review article published online by JAMA Dermatology. (2015-01-07)

CU School of Medicine's April Armstrong estimates cost of psoriasis in the US
The annual US cost of psoriasis, a chronic inflammatory skin condition, was estimated to be between $112 billion and $135 billion in 2013, according to a review article published online by JAMA Dermatology. (2015-01-07)

Psoriasis patients at high risk of diabetes
Patients with psoriasis are at high risk of new-onset diabetes mellitus, according to research presented at ESC Congress 2012. The findings were presented at the press conference by Dr Ole Ahlehoff from Copenhagen University Hospital, Gentofte, Denmark and at the scientific session by Usman KHALID. (2012-08-27)

Psoriasis researcher earns third NIH Grant in 1 year
Dermatology researcher Nicole Ward, PhD, has earned her third National Institutes of Health grant in a year -- including two that scored in the first percentile. With this most recent award, an R21, she will investigate the role the nervous system plays in psoriasis -- an inflammatory autoimmune disease characterized by raised areas of red, scaly, itchy and sometimes painful patches of skin. (2013-08-16)

Severe psoriasis predominantly affects men
The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionately affects men. A unique study with 5,438 Swedish psoriasis patients now reveals that women have a statistically significant lower incidence of severe psoriasis compared to men. The study, conducted by researchers at Umeå University and Karolinska Institutet, is published in the American Journal of Clinical Dermatology. (2017-03-24)

Higher levels of obesity-related hormone found in patients with psoriasis
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. (2008-12-15)

Page 1 of 14 | 534 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.